USPTO 2015–2025 USPTO PatentsView US Corporation

Silvergate Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 25 granted patents across 3 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Silvergate ranks #12,225 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 3 technology areas.

#12,225
of 49,997 US assignees by volume
36th percentile
by Innovation Score (30.8/100)
21.6
avg claims per patent
+8%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12225 · US Corporation #12,225 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 25 grants
  • UPPER-Q #12,225/49,997
  • PHOTO-FINISH Shenzhen Xingyingda…
  • CPC-NARROW A61K · 3 areas
  • INNOV-THIN 30.8/100
  • CLAIMS-DENSE 21.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT +8% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Shenzhen Xingyingda Industry Co., Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Silvergate’s 30.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Silvergate

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Silvergate's Innovation Score is 30.8/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Silvergate?

Each dot is one of Silvergate’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Silvergate’s own 21.6 claims/patent is ABOVE the 15.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Silvergate vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 24.924.92525.1 0510152025 Granted patents (volume) Avg claims / patent Shenzhen Xingyingda Industry Co., Ltd - 25, 1Shenzhen Xingying…Shinmaywa Industries, Ltd. - 25, 8.96Shinmaywa Industr…Sick Engineering GMBH - 25, 12.28Sick EngineeringSightful Computers Ltd - 25, 20Sightful ComputersSkyworks Panasonic Filter Solutions Japan Co., Ltd. - 25, 20.68Skyworks Panasoni…Smic New Technology Research and Development (Shanghai) Corporation - 25, 15.12Smic New Technolo…Solomon Systems, Inc. - 25, 15.44Solomon SystemsSony Pictures Technologies, Inc. - 25, 15.28Sony PicturesSilvergate Pharmaceuticals, Inc. - 25, 21.64Silvergate Pharma…
Silvergate vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Silvergate's grants concentrate

Silvergate Pharmaceuticals, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (7 grants) versus a trough of 1 in 2016. By volume, Silvergate sits between Shenzhen Xingyingda Industry Co., Ltd and Sony Pictures Technologies, Inc..

Silvergate's three-year grant acceleration

Silvergate Pharmaceuticals, Inc. shows 1 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Silvergate's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Silvergate holds 25 patents at rank #12,214, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Silvergate

By rank, the assignees closest to #12,214 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Silvergate's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Silvergate, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Silvergate ranks #906 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (31 here).

Silvergate's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2016201720182019202020212023 1
USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Silvergate Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 4.0%
2017 4 16.0%
2018 5 20.0%
2019 2 8.0%
2020 5 20.0%
2021 7 28.0%
2023 1 4.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Silvergate Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

  • Silvergate Pharmaceuticals, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #12,225 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Silvergate Pharmaceuticals, Inc. against Shenzhen Xingyingda Industry Co., Ltd, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 30.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.